Advisory Services Network’s Lexicon Pharmaceuticals LXRX Stock Holding History

Advisory Services Network’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,242	Closed	-$5.06K	–	3610
2026 Q1	$5.06K	Buy	+3,242	New	+$4.71K	﹤0.01%	3847
2025 Q4	–	Sell	-3,242	Closed	-$4.38K	–	3260
2025 Q3	$4.38K	Buy	+3,242	New	+$3.68K	﹤0.01%	3574
2024 Q1	–	Sell	-242	Closed	-$370	–	2735
2023 Q4	$370	Buy	+242	New	+$288	﹤0.01%	3663
2023 Q2	–	Sell	-242	Closed	-$588	–	2707
2023 Q1	$588	Hold	242	–	–	﹤0.01%	3716
2022 Q4	$462	Buy	+242	New	+$515	﹤0.01%	3751
2021 Q3	–	Sell	-242	Closed	-$1K	–	2469
2021 Q2	$1K	Buy	+242	New	+$1.17K	﹤0.01%	3478
2021 Q1	–	Sell	-242	Closed	-$1K	–	2275
2020 Q4	$1K	Hold	242	–	–	﹤0.01%	3159
2020 Q3	$0	Buy	+242	New	+$431	﹤0.01%	3602
2020 Q2	–	Sell	-242	Closed	–	–	2028
2020 Q1	$0	Hold	242	–	–	﹤0.01%	3182
2019 Q4	$1K	Buy	242 +100	+70%	+$385	﹤0.01%	2969
2019 Q3	$1K	Hold	142	–	–	﹤0.01%	2725
2019 Q2	$1K	Hold	142	–	–	﹤0.01%	2723
2019 Q1	$1K	Hold	142	–	–	﹤0.01%	2442
2018 Q4	$1K	Hold	142	–	–	﹤0.01%	2426
2018 Q3	$2K	Hold	142	–	–	﹤0.01%	2310
2018 Q2	$2K	Hold	142	–	–	﹤0.01%	2275
2018 Q1	$1K	Hold	142	–	–	﹤0.01%	2485
2017 Q4	$1K	Hold	142	–	–	﹤0.01%	2458
2017 Q3	$2K	Hold	142	–	–	﹤0.01%	2156
2017 Q2	$2K	Hold	142	–	–	﹤0.01%	2113
2017 Q1	$2K	Buy	+142	New	+$2.11K	﹤0.01%	1978
2016 Q3	$3K	Buy	+142	New	+$2.29K	﹤0.01%	1677

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Advisory Services Network's LXRX Position: Q2 2026 in Review

Advisory Services Network sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 3,242 shares — an estimated $5.06K sold.

Advisory Services Network first reported a position in LXRX in Q3 2016 and held it in 22 quarters. The position peaked at $5.06K in Q1 2026. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

Advisory Services Network reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 3,242 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $5.06K.
Advisory Services Network first reported a position in Lexicon Pharmaceuticals in Q3 2016 and held it in 22 quarters.
Advisory Services Network's Lexicon Pharmaceuticals position peaked at $5.06K in Q1 2026.
149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.